Allergan to sell a quarter of its Teva stake in first quarter of 2018 | Reuters
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Teva-Allergan deal a booster for Indian companies - The Economic Times
Allergan Generics acquired by Teva in $40.5bn deal — Financier Worldwide
Mayne vaults ahead in U.S. with $652M deal for Teva/Allergan meds | Fierce Pharma
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Teva, Allergan reach $107 million deal with Rhode Island over opioid crisis
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Allergan steps away from generics with sale to Teva | Business | Chemistry World
Teva nears deal for Allergan's generic drugs unit: source | Reuters.com
Teva drops bid for Mylan, buys Allergan's generics unit | Pittsburgh Post-Gazette
Birth Of A Giant: A Timeline Of Teva And Allergan's Generics Business :: Pink Sheet
Why Teva Paid $40.5 Billion for Allergan's Generic Business - Knowledge at Wharton
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva acquires Allergan's generics operations in $38.8bn deal - PMLiVE
Teva investors fret over $41bn generic drugs deal | Financial Times
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Mayne vaults ahead in U.S. with $652M deal for Teva/Allergan meds | Fierce Pharma
Teva Allergan Merger
Teva completes $40.5B Actavis deal, agrees to buy Anda for $500M - Philadelphia Business Journal
AbbVie, Teva reach $161.5 million opioid deal in W. Virginia | Crain's Chicago Business
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva Springs for $40.5B Allergan Generics Acquisition Instead of Mylan Bid - YouTube
